[HTML] springer.com

[HTML][HTML] Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”

M Puligheddu, M Figorilli, E Antelmi, D Arnaldi… - Neurological …, 2022 - Springer
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt α-
synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from …
被引用次数：13 相关文章

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”

M Puligheddu, M Figorilli, E Antelmi, D Arnaldi… - NEUROLOGICAL …, 2022 - iris.unica.it
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt α-
synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from …

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”

M Puligheddu, M Figorilli, E Antelmi, D Arnaldi… - NEUROLOGICAL …, 2022 - iris.unisr.it
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt α-
synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from …

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study" FARPRESTO"

M Puligheddu, M Figorilli, E Antelmi… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt α-
synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from …

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study" FARPRESTO"

M Puligheddu, M Figorilli, E Antelmi, D Arnaldi… - NEUROLOGICAL …, 2022 - iris.unipv.it
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt
alpha-synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years …

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study" FARPRESTO"

M Puligheddu, M Figorilli, E Antelmi, D Arnaldi… - NEUROLOGICAL …, 2022 - cris.unibo.it
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt
alpha-synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years …

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study" FARPRESTO".

M Puligheddu, M Figorilli, E Antelmi… - … : Official Journal of the …, 2022 - europepmc.org
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt α-
synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from …

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”

M Puligheddu, M Figorilli, E Antelmi… - NEUROLOGICAL …, 2022 - iris.unimore.it
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt α-
synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from …

Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”

M Puligheddu, M Figorilli, E Antelmi… - Neurological …, 2022 - search.proquest.com
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt α-
synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from …
[HTML] nih.gov

[HTML][HTML] Predictive risk factors of phenoconversion in idiopathic REM sleep behavior disorder: the Italian study “FARPRESTO”

M Puligheddu, M Figorilli, E Antelmi… - Neurological …, 2022 - ncbi.nlm.nih.gov
Most patients with idiopathic REM sleep behavior disorder (iRBD) will develop an overt α-
synucleinopathy over time, with a rate of phenoconversion of 73.5% after 12 years from …